Rohto Pharmaceutical Co (Rohto Pharmaceutical Co) Other Long Term Assets : $350.36 Mil (As of Dec. 2023)

View and export this data going back to 2010. Start your Free Trial

What is Rohto Pharmaceutical Co Other Long Term Assets?

Rohto Pharmaceutical Co's other long-term assets for the quarter that ended in Dec. 2023 was $350.36 Mil.

Rohto Pharmaceutical Co's quarterly other long-term assets increased from Jun. 2023 ($329.57 Mil) to Sep. 2023 ($335.00 Mil) and increased from Sep. 2023 ($335.00 Mil) to Dec. 2023 ($350.36 Mil).

Rohto Pharmaceutical Co's annual other long-term assets increased from Mar. 2022 ($322.07 Mil) to Mar. 2023 ($326.85 Mil) and increased from Mar. 2023 ($326.85 Mil) to Mar. 2024 ($357.71 Mil).

Rohto Pharmaceutical Co Other Long Term Assets Historical Data

The historical data trend for Rohto Pharmaceutical Co's Other Long Term Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Rohto Pharmaceutical Co Other Long Term Assets Chart

Rohto Pharmaceutical Co Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Other Long Term Assets

Get a 7-Day Free Trial

290.42

325.62

322.07

326.85

357.71

Rohto Pharmaceutical Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Other Long Term Assets	Get a 7-Day Free Trial															326.85	329.57	335.00	350.36	357.71

Rohto Pharmaceutical Co Other Long Term Assets Calculation

GuruFocus lists Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets under the "Total Long-Term Assets" section.

Other Long Term Assets includes following items:
Investment in Properties
Non-current Accounts Receivable
Non-current Note Receivables
Non-current Deferred Assets
Non-current Prepaid Assets
Defined Pension Benefit
Other (too numerous to list)
Some companies can do choose to report each of these items separately. Yet, there are a variety of Other Long Term Assets which are simply too numerous to list.

Rohto Pharmaceutical Co (Rohto Pharmaceutical Co) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Rohto Pharmaceutical Co Ltd (OTCPK:RPHCF) » Definitions » Other Long Term Assets

Comparable Companies

Traded in Other Exchanges

4527:Mexico 4527:Japan

Address

1-8-1, Tatsumi-nishi, Ikuno-ku, Osaka, JPN, 544-8666

Website

https://www.rohto.co.jp

Rohto Pharmaceutical Co Ltd is a Japan-based manufacturer and marketer of pharmaceutical products, cosmetics, and functional foods. It undertakes manufacture and sales activities mainly in the health and beauty care categories. The company comprises the four geographical reportable segments of Japan, America, Europe, and Asia. In each segment, it manufactures and sales eye care products including eye drops and eyewash preparations, skincare products including dermal medicines, lip balm, sunscreens, and functional cosmetics, among others, internal medicines and food products including gastrointestinal medicines, traditional Chinese herbal medicines and supplements, and other products and services, such as in-vitro test kits.

Rohto Pharmaceutical Co (Rohto Pharmaceutical Co) Headlines

From GuruFocus

Hennessy Japan Fund Comments on Rohto Pharmaceutical Co., Ltd.

By Vera Yuan Vera Yuan • 06-26-2014

Hennessy Japan Fund Semi-Annual Report April 30, 2014

By Vera Yuan Vera Yuan • 06-26-2014